Day in the Life: Clinical Trialist Drives Next-Gen AML Care

Naval Daver, MD, who leads a number of acute myeloid leukemia (AML) research trials at MD Anderson Cancer Center in Houston, looks forward to a future where the treatment for AML is truly personalized, with individualized immunotherapy driven by advances in technologies like artificial intelligence. “That time is not far off,” he said…